Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 5, 2026JAMA Internal Medicine

Continuous Glucose Monitoring in Type 2 Diabetes and Beyond

View Full Paper
Ask AI
Bookmark
Share

Authors

JDJustin A. DowerUniversity of New HavenMJMinna JohanssonSkåne University HospitalACAnne CampFair Haven Community Health Center

Discussion

Loading...

Member takes

Implication

Review of CGM effectiveness shows modest benefits for type 2 diabetes, indicating careful deployment is essential.

Key Points

  • The aim is to assess the evidence supporting continuous glucose monitoring (CGM) in type 2 diabetes and other populations.
  • Reviewed systematic reviews and meta-analyses of randomized trials evaluating CGM.
  • Focused on glycemic outcomes, hypoglycemia, and patient-reported outcomes.
  • Considered evidence from nonpregnant adults using CGM beyond type 1 diabetes.
  • CGM use in adults with type 2 diabetes resulted in a reduction in hemoglobin A1c by approximately 0.3% compared to finger-stick monitoring.
  • Some patients with type 2 diabetes experienced significantly greater benefits from CGM.
  • Limited evidence supports CGM use in individuals with prediabetes or obesity, suggesting caution in deployment.

Cite This Study

Dower et al. (2026) studied this question.

synapsesocial.com/papers/6a72e816226790f3706579c8https://doi.org/10.1001/jamainternmed.2026.2772
View Full Paper
Ask AI
Bookmark
Share